Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 129-137

  Neurohr, C ^a   Huppmann, P ^a   Leuschner, S ^a   Von Wulffen, W ^a   Meis, T ^a   Leuchte, H ^a   Ihle, F ^a   Zimmermann, G ^a   Baezner, C ^a   Hatz, R ^a   Winter, H ^a   Frey, L ^a   Ueberfuhr, P ^a   Bittmann, I ^b   Behr, J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bronchiolitis obliterans syndrome; eNOS; lung transplantation

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EXHALATION; FEMALE; FOLLOW UP; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT;

BRONCHIOLITIS OBLITERANS; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; RISK;

EID: 78650854703     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03327.x     Document Type: Article

References (34)

1. Kreider M, Kotloff RM,. Selection of candidates for lung transplantation. Proc Am Thorac Soc 2009; 6: 20-27.
2. Christie JD, Edwards LB, Aurora P, et al., The registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 2009; 28: 1031-1049.
3. Estenne M, Maurer JR, Boehler A, et al,. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
4. Verleden GM, Vos R, De Vleeschauwer SI, et al,. Obliterative bronchiolitis following lung transplantation: From old to new concepts? Transpl Int 2009; 22: 771-779. [Epub 2009 Mar 26]
5. Neurohr C, Huppmann P, Samweber B, et al,. Munich Lung Transplant Group. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients. J Heart Lung Transplant 2009; 28: 468-74. [Epub 2009 Mar 14]
6. Reynaud-Gaubert M, Thomas P, Gregoire R, et al,. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients. Eur J Cardiothorac Surg 2002; 21: 60-66.
7. Vanaudenaerde BM, Meyts I, Vos R, et al,. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 2008; 32: 832-843.
8. Hachem RR,. Lung allograft rejection: Diagnosis and management. Curr Opin Organ Transplant 2009; 14: 477-482.
9. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J,. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998; 17: 1255-1263.
10. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M,. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007; 26: 681-686.
11. Verleden GM, Dupont LJ, Van Raemdonck DE, Vanhaecke J,. Leuven Lung Transplant Group. Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004; 78: 730-733.
12. Gabbay E, Walters EH, Orsida B, et al,. Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase. Am J Respir Crit Care Med 2000; 162: 2182-2187.
13. Fisher AJ, Gabbay E, Small T, Doig S, Dark JH, Corris PA,. Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax 1998; 53: 454-458.
14. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G,. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84: 731-765.
15. Gabbay E, Fisher AJ, Small T, Leonard AJ, Corris PA,. Exhaled single-breath nitric oxide measurements are reproducible, repeatable and reflect levels of nitric oxide found in the lower airways. Eur Respir J 1998; 11: 467-472.
16. Gabbay E, Haydn Walters E, Orsida B, Whitford H, Ward C,. In stable lung transplant recipients, exhaled nitric oxide levels positively correlate with airway neutrophilia and bronchial epithelial iNOS. Am J Respir Crit Care Med 1999; 160: 2093-2099.
17. Van Muylem A, Knoop C, Estenne M,. Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Crit Care Med 2007; 175: 731-736. [Epub 2007 Jan 18]
18. Brugière O, Thabut G, Mal H, et al,. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome. Eur Respir J 2005; 25: 813-819.
19. Neurohr C, Huppmann P, Zimmermann G, et al,. Munich Lung Transplant Group. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation. Transpl Int 2009; 22: 635-643. [Epub 2009 Feb 2]
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC,. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
21. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
22. Antus B, Csiszer E, Czebe K, Horvath I,. Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: A longitudinal study. Clin Transplant 2005; 19: 377-382.
23. Silkoff PE, Caramori M, Tremblay L, et al,. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med 1998; 157: 1822-1828.
24. De Soyza A, Fisher AJ, Small T, Corris PA,. Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 2001; 164: 1209-1212.
25. Asher MI, Keil U, Anderson HR, et al,. International Study of Asthma and Allergies in Childhood (ISAAC): Rationale and methods. Eur Respir J 1995; 8: 483-491.
26. Busse WW, Rosenwasser LJ,. Mechanisms of asthma. J Allergy Clin Immunol 2003; 111 (3 Suppl): S799-S804.
27. Verleden GM, Dupont LJ, Delcroix M, et al,. Exhaled nitric oxide after lung transplantation: Impact of the native lung. Eur Respir J. 2003; 21: 429-432.
28. Nadziakiewicz P, Knapik P, Rozentryt P, et al,. Potential confounding factors in measurement of exhaled nitric oxide. J Physiol Pharmacol 2006; 57 (Suppl 4): 223-228.
29. Botha P, Archer L, Anderson RL, et al,. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85: 771-774.
30. Martin U, Bryden K, Devoy M, Howarth P,. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996; 97: 768-772.
31. Pucci S, Incorvaia C,. Allergy as an organ and a systemic disease. Clin Exp Immunol 2008; 153 (Suppl 1): 1-2.
32. Reid DW, Walters EH, Johns DP, et al,. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2005; 24: 489-492.
33. Williamson PA, Vaidyanathan S, Clearie K, Stewart M, Lipworth BJ,. Relationship between fractional exhaled nitric oxide and nasal nitric oxide in airways disease. Ann Allergy Asthma Immunol 2010; 105: 162-167. [Epub 2010 Jul 3]
34. Menzies D, Nair A, Lipworth BJ,. Portable exhaled nitric oxide measurement: Comparison with the "gold standard" technique. Chest 2007; 131: 410-414.